The Proove Platform
DashboardCreate Study

Your Studies

Manage and monitor your research studies

Ibogaine Outcomes Study

Active

ibogaine

1 / 100
18 weeks
Started Jan 8, 2026

Ketamine Therapy Outcomes Study

Active

Ketamine therapy

1 / 100
12 weeks
Started Jan 8, 2026

Vitamin D Supplementation Outcomes Study

Active

Vitamin D supplementation

0 / 100
26 weeks
Started Jan 8, 2026

Methylene Blue Outcomes Study

Active

methylene blue

2 / 100
12 weeks
Started Jan 8, 2026

BPC-157 Outcomes Study

Active

BPC-157

1 / 100
12 weeks
Started Jan 8, 2026

Estrogen Replacement Therapy Outcomes Study

Active

Estrogen replacement therapy

0 / 100
52 weeks
Started Jan 6, 2026

Estrogen Replacement Therapy Outcomes Study

Active

Estrogen replacement therapy

0 / 100
52 weeks
Started Jan 6, 2026

Intermittent Fasting Outcomes Study

Active

Intermittent fasting

0 / 100
26 weeks
Started Jan 6, 2026

intermittent fasting Outcomes Study

Active

intermittent fasting

0 / 100
12 weeks
Started Jan 6, 2026

Ketamine therapy Outcomes Study

Active

Ketamine therapy

0 / 100
12 weeks
Started Jan 5, 2026

TB-500 Outcomes Study

Active

TB-500

1 / 100
12 weeks
Started Jan 5, 2026

Testosterone replacement therapy Outcomes Study

Active

Testosterone replacement therapy

2 / 100
52 weeks
Started Jan 5, 2026

BPC-157 Outcomes Study

Active

BPC-157

3 / 100
26 weeks
Started Jan 5, 2026